about
Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosisDevelopment of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantationSoluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantationCritical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.Transient Suppression of TGFβ Receptor Signaling Facilitates Human Islet TransplantationIschemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activationABO-incompatible organ transplantation.B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway DiseaseInterleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice.Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA.Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation.T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft.Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression.Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.Natural antibodies prevent in vivo transmission of porcine islet-derived endogenous retrovirus to human cells.Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.Total Pancreatectomy with Islet Autotransplantation for the Ampullary Cancer. A Case Report.Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection.Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection.Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury.Xenoreactive anti-Galalpha(1,3)Gal antibodies prevent porcine endogenous retrovirus infection of human in vivoThe introduction of new vaccines into developing countries. III. The role of intellectual propertyImproved islet yields from pancreas preserved in perflurocarbon is via inhibition of apoptosis mediated by mitochondrial pathwayA significant role for histocompatibility in human islet transplantationComplement depletion enhances pulmonary inflammatory response after liver injuryMicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndromeLong-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes
P50
Q31126487-39E01578-F016-4C1E-8480-2547DAD18045Q33867260-1193E0EE-61EB-4075-BAC8-D7C28BAD3556Q34036197-B9977F61-07EE-4248-89BA-736EC91DC755Q34667420-D5FC96F5-5126-4722-923F-B98675E0FDB4Q34795394-AC88A5D9-DA14-4B15-A44B-71AB2CBAC59BQ35570778-98DDD3F9-F3D4-4441-AF09-46B16A73A164Q35952077-FCBA98B0-25CE-4806-8964-AA9257A32927Q36319913-5AC9DF26-7218-4850-9507-AA430543C7E9Q36547137-412E2F47-D2B0-4A22-A3B5-BFB675BE13FEQ36753835-4E072AD3-2672-4076-AFBD-9BFC90847AA0Q36910697-AF22B5C2-4CF5-45EF-B4DA-7F6E0B7CDF71Q37984656-0A6DF1B4-AA89-4D84-9F59-4D6FBACFD92BQ39356829-DC094891-2AC0-4C2C-86E3-0CFB44FB1077Q40124825-E7DFF646-2DF0-4763-A607-D0F91A98F8C2Q41527653-1E354404-F0CC-45CD-A75A-851615244778Q41703961-D6BB7CD5-2F67-410E-99DE-C6CB22C1DB03Q41830532-C07F71BC-8BC6-45D8-8564-B4E84A1EC53DQ41966454-FFC3BEB9-6E66-4CDB-87CD-2735447134C9Q42126102-33E901D9-1B3C-4A37-9A85-B6067B04DC7DQ42594941-24C50393-65A9-4D91-ABCD-BDD802DADB15Q43753094-C1DD7C68-76FC-433A-8AAB-BB5AB1C5228CQ47557792-FE4AA7F4-E2A6-436E-8F03-56C40B4B2868Q47641874-6C3A2CF9-CA08-4E49-B24C-D5C785C6C015Q47705702-44892AC9-9F89-4C2A-B52D-4DDAA5DE1E54Q48265692-1FE7ECB6-278B-492C-BD21-5EA22AC07B3CQ51962054-A32E3DDC-B19E-48D3-B97A-7567A8DB0B50Q53688825-D5EFC2F8-1BC3-4275-9E30-88FC7904E9A5Q54655064-07715AC2-4C86-4BD7-B2B6-F1BBAEB358FAQ73573968-19D61C50-DA13-4F58-9D7F-1F880D6FB4D1Q75325571-73E7A1F9-8D58-4AD9-9338-B6AC997DE2CFQ79859084-13BA04F9-59DF-4CCC-B6DE-AB973B5B474BQ79955732-E9270D53-7F2C-492F-A63F-6BA1B843A258Q82674789-66A82E18-A25C-4A21-9FAC-4804B87D1E35Q89119407-0B3E1E3C-126E-4C38-9358-6D12A7A9C837Q92377277-B5B60390-5C59-422C-B9BB-AE911B73FD80
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sabarinathan Ramachandran
@ast
Sabarinathan Ramachandran
@en
Sabarinathan Ramachandran
@es
Sabarinathan Ramachandran
@nl
type
label
Sabarinathan Ramachandran
@ast
Sabarinathan Ramachandran
@en
Sabarinathan Ramachandran
@es
Sabarinathan Ramachandran
@nl
prefLabel
Sabarinathan Ramachandran
@ast
Sabarinathan Ramachandran
@en
Sabarinathan Ramachandran
@es
Sabarinathan Ramachandran
@nl
P106
P1153
7203055770
P31
P496
0000-0003-2239-8083